Both Carboplatin and Bevacizumab Improve Pathological Complete Remission Rate in Neoadjuvant Treatment of Triple Negative Breast Cancer: A Meta-Analysis

• Xiao-song Chen ,

  Contributed equally to this work with: Xiao-song Chen, Ying Yuan

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Ying Yuan ,

  Contributed equally to this work with: Xiao-song Chen, Ying Yuan

  Affiliation Department of Radiology, Shanghai Ninth People’s Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• David H. Garfield,

  Affiliation University of Colorado Comprehensive Cancer Center, Aurora, Colorado, United States of America

  ⨯
• Jia-yi Wu,

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Ou Huang,

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Kun-wei Shen

  * E-mail: kwshen@medmail.com.cn

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯